SA
Shreyasi Agrawal
About Shreyasi Agrawal
Data last updated:
Shreyasi Agrawal is a Director at Aaja Residency Private Limited (since 2018) and Director at Anthias Biopharma Private Limited (since 2018). The companies operate in Travel and Hospitality and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1.69 Cr; the largest is Aaja Residency Private Limited at ₹1.25 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Nov 2018 | 1996 | ₹1.25 Cr (FY 2024) | Active | |
| Director | 26 Nov 2018 | 2018 | ₹43.8 Lakh (FY 2022) | Active |
Board colleagues of Shreyasi Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Angooridevi Jagdish Agrawal | 00419828 | Aaja Residency Private Limited | Director |
| Neel Paresh Gupta | 08142076 | Aaja Residency Private Limited | Director |
| Neeta Paresh Gupta | 08139490 | Aaja Residency Private Limited | Director |
| Rekha Anand Kanodia | 03110996 | Aaja Residency Private Limited | Director |
| Shalini Vinod Agarwal | 08286548 | Aaja Residency Private Limited , Anthias Biopharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shreyasi Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shreyasi Agrawal
Shreyasi Agrawal currently holds 2 directorships: Aaja Residency Private Limited (Director, since 19 Nov 2018, revenue ₹1.25 Cr (FY 2024)); Anthias Biopharma Private Limited (Director, since 26 Nov 2018, revenue ₹43.8 Lakh (FY 2022)).
Shreyasi Agrawal was first appointed on 19 Nov 2018 as Director at Aaja Residency Private Limited.
The 2 current companies of Shreyasi Agrawal that report revenue have a combined latest revenue of ₹1.69 Cr: Aaja Residency Private Limited ₹1.25 Cr (FY 2024); Anthias Biopharma Private Limited ₹43.8 Lakh (FY 2022).
The current boards of Shreyasi Agrawal's companies include Angooridevi Jagdish Agrawal (Aaja Residency Private Limited), Neel Paresh Gupta (Aaja Residency Private Limited), Neeta Paresh Gupta (Aaja Residency Private Limited), Rekha Anand Kanodia (Aaja Residency Private Limited), Shalini Vinod Agarwal (Aaja Residency Private Limited).